about
Chinese guidelines on the management of renal cell carcinoma (2015 edition)[Genetic polymorphisms of PDGFR associated with thrombocytopenia in Chinese patients with clear-cell metastatic renal cell carcinoma treated with sunitinib].Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysisGNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients.Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.[Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma].RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinomaSorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 studyFirst-line axitinib versus sorafenib in Asian patients with metastatic renal cell carcinoma: exploratory subgroup analyses of Phase III dataAxitinib in Combination With Toripalimab, a Humanized Immunoglobulin G4 Monoclonal Antibody Against Programmed Cell Death-1, in Patients With Metastatic Mucosal Melanoma: An Open-Label Phase IB TrialDevelopment of 99mTc-conjugated JS001 antibody for in vivo mapping of PD-1 distribution in murine
P50
Q26772206-4F972DD2-0E91-4401-B193-8983D22FB0D3Q33419526-BB5C795C-84DD-4287-AF31-8F1E8D89A226Q33430139-EA47F851-BBF4-48A8-8F84-C96A7DDDDEF1Q39516216-46062D87-437C-4ABF-834F-61A640C23CEDQ41573031-8D355198-B0E4-4BFE-9845-983B99B7E356Q50498244-7908FFE0-26BE-4597-A2B0-58AC004DB6F8Q52739376-3B63EF31-B1EF-4B8C-8E2A-12A0A6ECCA04Q53208703-4512E8BA-1CB7-424A-8E27-25057BAD649AQ64086083-3C200691-EA2C-453E-B10C-C90C3F613848Q89187696-44FFEA58-2F2B-4712-8C4B-D19198FCAAE5Q90607746-5765C6DD-EBF8-46AA-B30E-6FC2DA393610Q92562893-3A308FAD-5D1B-4B8A-AC7B-F063DC7EA446Q93138065-D8A423EB-123A-42B0-9700-FFBDB464B3E6
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Xinan Sheng
@en
Xinan Sheng
@nl
type
label
Xinan Sheng
@en
Xinan Sheng
@nl
prefLabel
Xinan Sheng
@en
Xinan Sheng
@nl
P31
P496
0000-0001-9359-0975